The role of LKB1 in lung cancer

Familial Cancer

Volumn 10, Issue 3, 2011, Pages 447-453

  Sanchez Cespedes, Montse ^a  

^a HOSPITAL DURAN I REYNALS   (Spain)

Author keywords

BRG1; LKB1 (or STK11); Lung cancer; Peutz Jeghers; SMARCA4

Indexed keywords

1 (1 CYANO 1 METHYLETHYL) 3 METHYL 8 (3 QUINOLINYL)IMIDAZO[4,5 C]QUINOLIN 2(1H,3H) ONE; AZD 2644; BRG1 PROTEIN; DASATINIB; METFORMIN; PROTEIN KINASE LKB1; PROTEIN TYROSINE KINASE INHIBITOR; RAPAMYCIN; SUNITINIB; UNCLASSIFIED DRUG;

CANCER GENETICS; CANCER THERAPY; CHROMOSOME 19P; CONFERENCE PAPER; GENE INACTIVATION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; LUNG CANCER; NONHUMAN; PRIORITY JOURNAL;

GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES;

EID: 80054985539     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-011-9443-0     Document Type: Conference Paper

References (61)

1. DM Parkin F Bray J Ferlay P Pisan 2001 Estimating the world cancer burden: globocan 2000 Int J Cancer 94 153 156 11668491 10.1002/ijc.1440 1:CAS:528:DC%2BD3MXntVGlu78%3D (Pubitemid 32911406)
2. RJC Slebos RH Hruban O Dalesio, et al. 1991 Relationship between K-ras oncogene activation and smoking in adenocarcinomas of the human lung J Natl Cancer Inst 83 1024 1027 2072410 10.1093/jnci/83.14.1024 1:STN:280: DyaK3MzgtlGquw%3D%3D
3. MS Greenblatt WP Bennett M Hollstein CC Harris 1994 Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis Cancer Res 54 4855 4878 8069852 1:CAS:528:DyaK2cXlslKgsLw%3D (Pubitemid 24289415)
4. Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC (eds) (2004) World Health Organization classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart. IARC Press, Lyon
5. A Bhattacharjee WG Richards J Staunton, et al. 2001 Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses Proc Natl Acad Sci USA 98 13790 13795 11707567 10.1073/pnas.191502998 1:CAS:528:DC%2BD3MXovVynt7s%3D (Pubitemid 33115977)
6. ME Garber OG Troyanskaya K Schluens, et al. 2001 Diversity of gene expression in adenocarcinoma of the lung Proc Natl Acad Sci USA 98 13784 13789 11707590 10.1073/pnas.241500798 1:CAS:528:DC%2BD3MXovVynt7o%3D (Pubitemid 33115976)
7. B Angulo A Suarez-Gauthier F Lopez-Rios, et al. 2008 Expression signatures in lung cancer shows a profile for EGFR-mutant tumors and identifies selective PIK3CA overexpression by gene amplification J Pathol 214 347 356 17992665 10.1002/path.2267 1:CAS:528:DC%2BD1cXivVSgt7Y%3D (Pubitemid 351212390)
8. M Sanchez-Cespedes 2003 Dissecting the genetic alterations involved in lung carcinogenesis Lung Cancer 40 111 121 12711111 10.1016/S0169-5002(03)00033- 3 (Pubitemid 36438711)
9. L Ding G Getz DA Wheeler, et al. 2008 Somatic mutations affect key pathways in lung adenocarcinoma Nature 455 1069 1075 18948947 10.1038/nature07423 1:CAS:528:DC%2BD1cXht1yju73J
10. R Blanco R Iwakawa M Tang, et al. 2009 A gene-alteration profile of human lung cancer cell lines Hum Mutat 30 1199 1206 19472407 10.1002/humu.21028 1:CAS:528:DC%2BD1MXhtVKrtrbJ
11. TJ Lynch DW Bell R Sordella, et al. 2004 Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N Engl J Med 20 2129 2139 10.1056/NEJMoa040938 (Pubitemid 38637993)
12. W Pao V Miller M Zakowski, et al. 2004 EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib Proc Natl Acad Sci USA 101 13306 13311 15329413 10.1073/pnas.0405220101 1:CAS:528:DC%2BD2cXnvFems70%3D (Pubitemid 39209661)
13. JG Paez PA Janne JC Lee, et al. 2004 EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 1497 1500 15118125 10.1126/science.1099314 1:CAS:528:DC%2BD2cXksVGmsbs%3D (Pubitemid 38720929)
14. A Hemminki D Markie I Tomlinson, et al. 1998 A serine/threonine kinase gene defective in Peutz-Jeghers syndrome Nature 18 184 187 (Pubitemid 28092478)
15. DE Jenne H Reimann J Nezu, et al. 1998 Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase Nat Genet 18 38 44 9425897 10.1038/ng0198-38 1:CAS:528:DyaK1cXivFelsw%3D%3D (Pubitemid 28027876)
16. FM Giardiello SB Welsh SR Hamilton, et al. 1987 Increased risk of cancer in the Peutz-Jeghers syndrome N Engl J Med 316 1511 1514 3587280 10.1056/NEJM198706113162404 1:STN:280:DyaL2s3ivVylsw%3D%3D (Pubitemid 17076235)
17. MG van Lier A Wagner EM Mathus-Vliegen, et al. 2010 High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations Am J Gastroenterol 105 1258 1264 20051941 10.1038/ajg.2009.725
18. AK Virmani KM Fong D Kodagoda, et al. 1998 Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types Genes Chrom Cancer 21 308 319 9559342 10.1002/(SICI)1098-2264(199804)21: 4<308::AID-GCC4>3.0.CO;2-2 1:STN:280:DyaK1c3itVSqtA%3D%3D (Pubitemid 28165038)
19. M Sanchez-Cespedes P Parrella M Esteller, et al. 2002 Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung Cancer Res 62 3659 3662 12097271 1:CAS:528:DC%2BD38XltF2jtLo%3D (Pubitemid 34728843)
20. J Carretero PP Medina R Pio, et al. 2004 Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene Oncogene 23 4037 4040 15021901 10.1038/sj.onc.1207502 1:CAS:528:DC%2BD2cXjvVKgurg%3D (Pubitemid 38747933)
21. M Sanchez-Cespedes 2007 A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome Oncogene 26 7825 7832 17599048 10.1038/sj.onc.1210594 1:CAS:528:DC%2BD2sXhsVaisr7E (Pubitemid 350261789)
22. H Ji MR Ramsey DN Hayes, et al. 2007 LKB1 modulates lung cancer differentiation and metastasis Nature 448 807 810 17676035 10.1038/nature06030 1:CAS:528:DC%2BD2sXptVGrs7g%3D (Pubitemid 47266337)
23. S Matsumoto R Iwakawa K Takahashi, et al. 2007 Prevalence and specificity of LKB1 genetic alterations in lung cancers Oncogene 26 5911 5918 17384680 10.1038/sj.onc.1210418 1:CAS:528:DC%2BD2sXps12nur0%3D
24. CL Mahoney B Choudhury H Davies, et al. 2009 LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition Br J Cancer 100 370 375 19165201 10.1038/sj.bjc.6604886 1:CAS:528:DC%2BD1MXpsVSrsg%3D%3D
25. AG Knudson 1971 Mutation and cancer: statistical study of retinoblastoma Proc Natl Acad Sci USA 68 820 823 5279523 10.1073/pnas.68.4.820
26. H Ghaffar F Sahin M Sanchez-Cespedes, et al. 2003 LKB1 protein expression in the evolution of glandular neoplasia of the lung Clin Cancer Res 9 2998 3003 12912948 1:CAS:528:DC%2BD3sXmtF2hsrg%3D (Pubitemid 36993259)
27. E Conde A Suarez-Gauthier E Garcia-Garcia, et al. 2007 Specific pattern of LKB1 and phospho-acetyl-CoA carboxylase protein immunostaining in human normal tissues and lung carcinomas Hum Pathol 38 1351 1360 17521700 10.1016/j.humpath.2007.01.022 1:CAS:528:DC%2BD2sXpt1entbw%3D (Pubitemid 47247478)
28. H Mehenni C Gehrig J Nezu, et al. 1998 Loss of LKB1 kinase activity in Peutz-Jeghers syndrome, and evidence for allelic and locus heterogeneity Am J Hum Genet 63 1641 1650 9837816 10.1086/302159 1:CAS:528:DyaK1MXltF2qtg%3D%3D (Pubitemid 30415726)
29. A Ylikorkala E Avizienyte IP Tomlinson, et al. 1999 Mutations and impaired function of LKB1 in familial and non-familial Peutz-Jeghers syndrome and a sporadic testicular cancer Hum Mol Genet 8 45 51 9887330 10.1093/hmg/8.1.45 1:CAS:528:DyaK1MXoslemtQ%3D%3D (Pubitemid 29039047)
30. SA Hawley J Boudeau JL Reid, et al. 2003 Complexes between the LKB1 tumor suppressor, STRADalpha/beta and MO25alpha/beta are upstream kinases in the AMP-activated protein kinase cascade J Biol 2 28 14511394 10.1186/1475-4924-2-28
31. AK Wong F Shanahan Y Chen, et al. 2000 BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines Cancer Res 60 6171 6177 11085541 1:CAS:528:DC%2BD3cXotV2lsbk%3D
32. PP Medina OA Romero T Kohno, et al. 2008 Frequent BRG1/SMARCA4- inactivating mutations in human lung cancer cell lines Hum Mutat 29 617 622 18386774 10.1002/humu.20730 1:CAS:528:DC%2BD1cXmsVOnsr8%3D (Pubitemid 351614585)
33. S Rodriguez-Nieto M Sanchez-Cespedes 2009 BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer Carcinogenesis 30 547 554 19176640 10.1093/carcin/bgp035 1:CAS:528:DC%2BD1MXktFSrur0%3D
34. M Tiainen A Ylikorkala TP Makela 1999 Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest Proc Natl Acad Sci USA 96 9248 9251 10430928 10.1073/pnas.96.16.9248 1:CAS:528:DyaK1MXltVequ74%3D (Pubitemid 29374740)
35. P Marignani F Kanai CL Carpenter 2001 LKB1 associates with Brg1 and is necessary for Brg1-induced growth arrest J Biol Chem 276 32415 32418 11445556 10.1074/jbc.C100207200 1:CAS:528:DC%2BD3MXmvFCnu7c%3D
36. AI Jimenez P Fernandez O Dominguez, et al. 2003 Growth and molecular profile of lung cancer cells expressing ectopic LKB1: down-regulation of the phosphatidylinositol 3'-phosphate kinase/PTEN pathway Cancer Res 63 1382 1388 12649203 1:CAS:528:DC%2BD3sXit1Sgurg%3D (Pubitemid 36348721)
37. P Karuman O Gozani RD Odze, et al. 2001 The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death Mol Cell 7 1307 1319 11430832 10.1016/S1097-2765(01)00258-1 1:CAS:528:DC%2BD3MXkvVaqu7c%3D (Pubitemid 32607363)
38. M Nakau H Miyoshi MF Seldin, et al. 2002 Hepatocellular carcinoma caused by loss of heterozygosity in lkb1 gene knockout mice Cancer Res 62 4549 4553 12183403 1:CAS:528:DC%2BD38XmsVShsr0%3D
39. H Miyoshi M Nakau TO Ishikawa, et al. 2002 Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice Cancer Res 62 2261 2266 11956081 1:CAS:528:DC%2BD38Xjt1ejtLc%3D (Pubitemid 34411702)
40. A Ylikorkala DJ Rossi N Korsisaari, et al. 2001 Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice Science 293 1323 1326 11509733 10.1126/science.1062074 1:CAS:528:DC%2BD3MXmtFGjur0%3D (Pubitemid 32777423)
41. AF Baas J Boudeau GP Sapkota, et al. 2003 Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD EMBO J 22 3062 3072 12805220 10.1093/emboj/cdg292 1:CAS:528:DC%2BD3sXks1Wru7g%3D (Pubitemid 36758626)
42. J Boudeau AF Baas M Deak, et al. 2003 MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm EMBO J 22 5102 5114 14517248 10.1093/emboj/cdg490 1:CAS:528:DC%2BD3sXnvVeqtb8%3D (Pubitemid 37222030)
43. DG Hardie 2003 Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status Endocrinology 144 5179 5183 12960015 10.1210/en.2003-0982 1:CAS:528:DC%2BD3sXpsV2gtL4%3D (Pubitemid 37476044)
44. MN Corradetti K Inoki N Bardeesy, et al. 2004 Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome Genes Dev 18 1533 1538 15231735 10.1101/gad.1199104 1:CAS:528:DC%2BD2cXlslWnurY%3D (Pubitemid 38868905)
45. RJ Shaw N Bardeesy BD Manning, et al. 2004 The LKB1 tumor suppressor negatively regulates mTOR signaling Cancer Cell 6 91 99 15261145 10.1016/j.ccr.2004.06.007 1:CAS:528:DC%2BD2cXmtlKntL4%3D (Pubitemid 38903165)
46. J Carretero PP Medina R Blanco, et al. 2007 Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer Oncogene 26 1616 1625 16953221 10.1038/sj.onc.1209951 1:CAS:528:DC%2BD2sXisFynsLY%3D (Pubitemid 46398737)
47. P Fernandez J Carretero PP Medina, et al. 2004 Distinctive gene expression of human lung adenocarcinomas carrying LKB1 gene mutations Oncogene 23 5084 5091 15077168 10.1038/sj.onc.1207665 1:CAS:528:DC%2BD2cXltVOnsrw%3D (Pubitemid 38938742)
48. JM Lizcano O Goransson R Toth, et al. 2004 LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1 EMBO J 23 833 843 14976552 10.1038/sj.emboj.7600110 1:CAS:528:DC%2BD2cXhsFCjtbs%3D (Pubitemid 38418750)
49. S Guo KJ Kemphues 1995 par-1, a gene required for establishing polarity in C. elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed Cell 81 611 620 7758115 10.1016/0092-8674(95)90082-9 1:CAS:528:DyaK2MXlvVGgurc%3D
50. SG Martin D St Johnston 2003 A role for Drosophila LKB1 in anterior-posterior axis formation and epithelial polarity Nature 421 379 384 12540903 10.1038/nature01296 1:CAS:528:DC%2BD3sXlsVansw%3D%3D (Pubitemid 36157936)
51. AF Baas J Kuipers NN van der Wel, et al. 2004 Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD Cell 116 457 466 15016379 10.1016/S0092-8674(04)00114-X 1:CAS:528:DC%2BD2cXhsFagt74%3D (Pubitemid 38366321)
52. S Zhang K Schafer-Hales FR Khuri, et al. 2008 The tumor suppressor LKB1 regulates lung cancer cell polarity by mediating cdc42 recruitment and activity Cancer Res 68 740 748 18245474 10.1158/0008-5472.CAN-07-2989 1:CAS:528:DC%2BD1cXhtlygsLs%3D (Pubitemid 351206750)
53. Roy BC, Kohno T, Iwakawa R et al (2010) Involvement of LKB1 in epithelial-mesenchymal transition (EMT) of human lung cancer cells. Lung Cancer. doi: 10.1016/j.lungcan.2010.02.004
54. J Carretero T Shimamura K Rikova, et al. 2010 Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors Cancer Cell 17 5 47 59
55. T Komiya A Coxon Y Park, et al. 2010 Enhanced activity of the CREB co-activator Crtc1 in LKB1 null lung cancer Oncogene 29 1672 1680 20010869 10.1038/onc.2009.453 1:CAS:528:DC%2BD1MXhsFGmsLnO
56. JM Evans LA Donnelly AM Emslie-Smith, et al. 2005 Metformin and reduced risk of cancer in diabetic patients BMJ 330 1304 1305 15849206 10.1136/bmj.38415.708634.F7 (Pubitemid 40813563)
57. RL Elstrom DE Bauer M Buzzai, et al. 2004 Akt stimulates aerobic glycolysis in cancer cells Cancer Res 64 3892 3899 15172999 10.1158/0008-5472. CAN-03-2904 1:CAS:528:DC%2BD2cXksVKnsrs%3D (Pubitemid 38697301)
58. M Buzzai DE Bauer RG Jones, et al. 2005 The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation Oncogene 24 4165 4173 15806154 10.1038/sj.onc.1208622 1:CAS:528:DC%2BD2MXltFKjt78%3D (Pubitemid 40961771)
59. RM Memmott JJ Gills M Hollingshead, et al. 2008 Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells Cancer Res 68 580 588 18199555 10.1158/0008-5472.CAN-07-3091 1:CAS:528:DC%2BD1cXmt1OlsQ%3D%3D (Pubitemid 351380087)
60. E Conde B Angulo M Tang, et al. 2006 Molecular context of the EGFR mutations: evidence for the activation of mTOR/S6 K signaling Clin Cancer Res 12 710 717 16467080 10.1158/1078-0432.CCR-05-1362 1:CAS:528:DC%2BD28XhtFeitbw%3D (Pubitemid 43259849)
61. L Gandhi KL McNamara D Li, et al. 2009 Sunitinib prolongs survival in genetically engineered mouse models of multistep lung carcinogenesis Cancer Prev Res 2 330 337 10.1158/1940-6207.CAPR-08-0213 1:CAS:528:DC%2BC3cXptFKgu78%3D